1. Development of In Vitro–In Vivo Correlation for Extended‐Release Niacin After Administration of Hypromellose‐Based Matrix Formulations to Healthy Volunteers. Issue 11 (24th September 2014) Authors: Kesisoglou, Filippos; Rossenu, Stefaan; Farrell, Colm; Van Den Heuvel, Michiel; Prohn, Marita; Fitzpatrick, Shaun; De Kam, Pieter‐Jan; Vargo, Ryan Journal: Journal of pharmaceutical sciences Issue: Volume 103:Issue 11(2014:Nov.) Page Start: 3713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Suitability of a Minipig Model in Assessing Clinical Bioperformance of Matrix and Multiparticulate Extended‐Release Formulations for a BCS Class III Drug Development Candidate. Issue 2 (30th December 2013) Authors: Kesisoglou, Filippos; Xie, Iris Huizhi; Manser, Kimberly; Wu, Yunhui; Hardy, Ian; Fitzpatrick, Shaun Journal: Journal of pharmaceutical sciences Issue: Volume 103:Issue 2(2014:Feb.) Page Start: 636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗